Indeed, the main finding obtained here was the demonstration that colon cancer cells displaying different genetic contexts and drug-resistant profiles can be sensitized to treatment by coordinating with HIF-2α depletion expression/inhibition with autophagy inhibition. Here, EPAS1 is linked to malignant colon neoplasm.